140 related articles for article (PubMed ID: 19546546)
1. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.
Dooley S; Weng H; Mertens PR
Dig Dis; 2009; 27(2):93-101. PubMed ID: 19546546
[TBL] [Abstract][Full Text] [Related]
2. TGF-β signaling in onset and progression of hepatocellular carcinoma.
Meindl-Beinker NM; Matsuzaki K; Dooley S
Dig Dis; 2012; 30(5):514-23. PubMed ID: 23108308
[TBL] [Abstract][Full Text] [Related]
3. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
[TBL] [Abstract][Full Text] [Related]
4. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta/Smad signaling in the injured liver.
Breitkopf K; Godoy P; Ciuclan L; Singer MV; Dooley S
Z Gastroenterol; 2006 Jan; 44(1):57-66. PubMed ID: 16397841
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis.
Zindy PJ; L'Helgoualc'h A; Bonnier D; Le Béchec A; Bourd-Boitin K; Zhang CX; Musso O; Glaise D; Troadec MB; Loréal O; Turlin B; Léger J; Clément B; Théret N
Hepatology; 2006 Nov; 44(5):1296-307. PubMed ID: 17058241
[TBL] [Abstract][Full Text] [Related]
8. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
Yamazaki K; Masugi Y; Sakamoto M
Dig Dis; 2011; 29(3):284-8. PubMed ID: 21829019
[TBL] [Abstract][Full Text] [Related]
10. Biology of transforming growth factor beta in hepatocarcinogenesis.
Rossmanith W; Schulte-Hermann R
Microsc Res Tech; 2001 Feb; 52(4):430-6. PubMed ID: 11170302
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta and hepatocellular carcinoma.
Bortolami M; Cardin R; Kotsafti A; Farinati F
Hepatology; 2008 Mar; 47(3):1095; author reply 1095-6. PubMed ID: 18306219
[No Abstract] [Full Text] [Related]
12. TGF-beta and cancer.
Bierie B; Moses HL
Cytokine Growth Factor Rev; 2006; 17(1-2):29-40. PubMed ID: 16289860
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.
Bae HJ; Eun JW; Noh JH; Kim JK; Jung KH; Xie HJ; Park WS; Lee JY; Nam SW
Oncol Rep; 2009 Sep; 22(3):475-80. PubMed ID: 19639191
[TBL] [Abstract][Full Text] [Related]
14. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
Levy L; Hill CS
Cytokine Growth Factor Rev; 2006; 17(1-2):41-58. PubMed ID: 16310402
[TBL] [Abstract][Full Text] [Related]
15. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
16. Proteomics of TGF-beta signaling and its impact on breast cancer.
Souchelnytskyi S
Expert Rev Proteomics; 2005 Dec; 2(6):925-35. PubMed ID: 16307521
[TBL] [Abstract][Full Text] [Related]
17. [Role and mechanism of cytokines in the carcinogenesis of liver carcinoma].
Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):378-9. PubMed ID: 15918976
[No Abstract] [Full Text] [Related]
18. TGF-β and Hepatocellular Carcinoma: When A Friend Becomes An Enemy.
Arrese M; Hernandez A; Astete L; Estrada L; Cabello-Verrugio C; Cabrera D
Curr Protein Pept Sci; 2018; 19(12):1172-1179. PubMed ID: 29150921
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma.
Giannelli G; Villa E; Lahn M
Cancer Res; 2014 Apr; 74(7):1890-4. PubMed ID: 24638984
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta (TGF-beta) and brain tumours.
Luwor RB; Kaye AH; Zhu HJ
J Clin Neurosci; 2008 Aug; 15(8):845-55. PubMed ID: 18550374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
